Nantahala Capital Management, Llc, Ten Percent Owner at Sucampo Pharmaceuticals, holds 148.15K shares in Evoke Pharma (Ticker: EVOK), holds 1.99M shares in Talphera (Ticker: TLPH), holds 0.00 shares in GUE Liquidation Companies (Ticker: FTDCQ). Most recently, Nantahala Capital Management, Llc Sold ― shares of Evoke Pharma on Jan 30, 2025 for an estimated value of 179.58.
What was Nantahala Capital Management, Llc’s latest transaction?
Nantahala Capital Management, Llc latest transaction was an Informative Sell of $179.58.
What was Nantahala Capital Management, Llc's most profitable transaction?
Nantahala Capital Management, Llc’s most profitable transaction was an Informative Buy of TLPH stock on March 15, 2024. The return on the trade was -40.80%.
What is Nantahala Capital Management, Llc's role in Sucampo Pharmaceuticals?
Nantahala Capital Management, Llc's role in Sucampo Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.